Post by Bell Potter Securities

Bell Potter is delighted to have acted as Lead Manager and Bookrunner to 4DMedical Limited’s (ASX: 4DX) $83 million Private Placement. 4DMedical is a global leader in respiratory imaging technology through its CT:VQ™ technology, the world’s first and only non-contrast, CT-based ventilation-perfusion imaging technology Announced simultaneously with receiving its CE Mark certification for commercial use in the EU, 4DX has placed $83m worth of shares via a private placement to accelerate commercialisation in the EU. This capital raise was demand led by existing supporters and underscores the momentum and execution success the 4DX team has achieved in the U.S. Congratulations to Andreas Fouras, Julian Sutton, Matt Tucker and the 4DX team, and the Bell Potter Team including Andrew James, James Berman, Daniel Goodman, Dermott Wilson, James Benetti, Jake Edwards and Tommy Unger on the successful Capital Raise. Disclosure: Bell Potter Securities acted as Lead Manager and Bookrunner to the $83m ASX Capital Raise for 4DMedical Limited and received fees for that service.